Atlanta, GA - The longest-term follow-up data available to date for drug-eluting stents in de novo lesions were presented here today at the American College of Cardiology 51st Annual Scientific ...

Against this background, the current study aimed to analyze overall outcomes with respect to the presence or absence of mismatches at any HLA locus involving A, B, C and DRB1 in a series of patients ...

Phase I trial of CG53135–05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT) No significant financial ...

Rochester, MN - Use of sirolimus in immunosuppressive protocols in kidney transplantation provides excellent patient and allograft survival with low rates of acute rejection and may provide an ...

Patients treated with tacrolimus (TAC) and mycophenolate mofetil (MMF) had lower rejection rates and better kidney function. A multi-year study compared three commonly used immunosuppresive regimens.

A new drug combination with the potential to extend patient survival in lung transplant recipients has been identified. Sirolimus plus Tacrolimus combination helps in the long-term prevention of ...

Researchers have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug ...

In a long-term randomized trial of 150 kidney transplant recipients with a median follow-up of eight years post-transplant, those undergoing immunosuppressive therapy with tacrolimus/mycophenolate ...

Please provide your email address to receive an email when new articles are posted on . A new study demonstrates that the immunosuppressive drug Tacrolimus directly activates the replication of the BK ...

The appraisal committee considered evidence from a number of sources. See the committee papers for full details of the evidence. The appraisal included 9 drugs for immunosuppression after kidney ...